Using phenotypic, functional and molecular approaches we demonstrate an increase of CD4+CD25highFOXP3+ Treg cells in colorectal cancer patients already before initiation of an IL-2 containing chemoimmunotherapy regimen. The gene discussed is IL2; the disease is colorectal cancer.